WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 92
GDP / capita (US$): 75'7001 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 423  417  411  406  399  331  257  193 
Births
Surviving infants
Pop. less than 5 years 34  33  32  31  30  34  34  29 
Pop. less than 15 years 98  98  98  98  99  101  89  74 
Female 15-49 years 120  119  118  117  116  99  68  46 

Number of reported cases

(Click for retrospective incidence data for Brunei Darussalam)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  42  12  485 
Mumps
ChartChart
  14  19  33 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Brunei Darussalam)
Vaccine year result method % card seen                                                
BCG          99*  99*  99*  99*  96  99*  95 
DTP1          99*  99*  99*  99*  96  99 
DTP3          99  99  99*  90  97  99  99*  89 
DTP4          86  96 
IPV1          99*  99* 
HepB_BD          99*  99*  99*  95  95  99* 
HepB3          99  99  98  99*  93  99*  96 
Hib3          99  96  99*  90  97 
JapEnc         
MCV1          96  97  96  99  91  99  73 
MCV2          97  96  92  96  93 
PCV1         
PCV3         
Pol3          99*  99  99  90  99*  99  99*  89 
Rota1         
RotaC         
Rubella1          96  97  99  91 
TT2plus          74  64  79  56  78  72 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Brunei Darussalam)
BCG
ChartChart
  99  99  99  99  96  99  91  99 
DTP1
ChartChart
  99  99  99  98  99  99  97  96 
DTP3
ChartChart
  99  99  99  90  97  99  93  89 
HepB3
ChartChart
  99  99  98  99  93  99 
HepB_BD
ChartChart
  99  99  99  95  95  99 
Hib3
ChartChart
  99  96  99  90  97 
MCV1
ChartChart
  96  97  96  99  91  99  99  73 
MCV2
ChartChart
  97  96  92  96  93  95 
PAB
ChartChart
  95  95  95  95  95  77  40 
PCV3
ChartChart
 
Pol3
ChartChart
  99  99  99  90  95  99  92  89 
RCV1
ChartChart
  96  97  96  99  91  99  99 
RotaC
ChartChart
 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepIPV 2, 4, 6 months; Yes
DTaPIPV 5 years; Yes
HIB 1 year; Yes
HPV 13 years (x3); and catch for female students
HepB birth; Yes
Influenza_Adult Yes and also chronic illness, pregnant women, health care workers, Haj and travellers
Influenza_Pediatric < 2 years; high risk groups
MMR 12, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR       Yes  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number        

System performance

Total Nº districts in country number  
Nº districts with DTP3 coverage >=80% number      
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100        100  100 
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100        100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No    No  No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes    No  No  No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%             100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No    No  No  No   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.